Principal Investigators Paul Barone , Jacqueline Wolfrum
Co-investigator Stacy Springs
Project Website http://consortiapedia.fastercures.org/consortia/bioman/
The Center for Biomedical Innovation (CBI) is addressing profound challenges in the global biomedical industry by developing, testing, and disseminating new knowledge and tools designed for real-world application through the following programs: Biomanufacturing Program (BioMAN), Consortium on Adventitious Agents in Biomanufacturing (CAACB), and New Drug Development Paradigms (NEWDIGS). CBI was established in 2005 and merged with Massachusetts Institute of Technology’s (MIT’s) Program on the Pharmaceutical Industry (POPI) in 2008. POPI was founded in 1991 with a major grant from the Alfred P. Sloan Foundation to promote research and educational activities on issues related to competitiveness, performance, and productivity in the pharmaceutical field.